ArticleScientific data2025
Multi-omic assessment of mRNA translation dynamics in liver cancer cell lines.
Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- RiboScreenBiomedicines · 2026Review
- Bridging single-molecule and genome-wide studies of cellular mRNA translation.RNA (New York, N.Y.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The limited correlation between mRNA and protein levels within cells highlighted the need to study mechanisms of translational control. To decipher the factors that determine the rates of individual steps in mRNA translation, machine learning approaches are currently applied to large libraries of synthetic constructs, whose properties are generally different from those of endogenous mRNAs. To fill this gap and thus enable the discovery of elements driving the translation of individual endogenous mRNAs, we here report steady-state and dynamic multi-omics data from human liver cancer cell lines, specifically (i) ribosome profiling data from unperturbed cells as well as following the block of translation initiation (ribosome run-off, to trace translation elongation), (ii) protein synthesis rates estimated by pulsed stable isotope labeled amino acids in cell culture (pSILAC), and (iii) mean ribosome load on individual mRNAs determined by mRNA sequencing of polysome fractions (polysome profiling). These data will enable improved predictions of mRNA sequence-dependent protein output, which is crucial for engineering protein expression and for the design of mRNA vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.